State Street’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.44M | Buy |
1,112,705
+835,676
| +302% | +$1.83M | ﹤0.01% | 3241 |
|
|
2025
Q1 | $299K | Buy |
277,029
+49,300
| +22% | +$53.2K | ﹤0.01% | 3733 |
|
|
2024
Q4 | $237K | Buy |
227,729
+53,200
| +30% | +$55.3K | ﹤0.01% | 3807 |
|
|
2024
Q3 | $218K | Buy |
174,529
+40,500
| +30% | +$50.6K | ﹤0.01% | 3807 |
|
|
2024
Q2 | $159K | Buy |
134,029
+36,900
| +38% | +$43.9K | ﹤0.01% | 3881 |
|
|
2024
Q1 | $98.1K | Hold |
97,129
| – | – | ﹤0.01% | 4033 |
|
|
2023
Q4 | $103K | Hold |
97,129
| – | – | ﹤0.01% | 4052 |
|
|
2023
Q3 | $159K | Hold |
97,129
| – | – | ﹤0.01% | 3993 |
|
|
2023
Q2 | $152K | Hold |
97,129
| – | – | ﹤0.01% | 4091 |
|
|
2023
Q1 | $139K | Buy |
97,129
+25,400
| +35% | +$36.3K | ﹤0.01% | 4200 |
|
|
2022
Q4 | $169K | Buy |
71,729
+13,523
| +23% | +$31.9K | ﹤0.01% | 4171 |
|
|
2022
Q3 | $118K | Buy |
58,206
+6,970
| +14% | +$14.1K | ﹤0.01% | 4398 |
|
|
2022
Q2 | $114K | Hold |
51,236
| – | – | ﹤0.01% | 4469 |
|
|
2022
Q1 | $342K | Buy |
51,236
+13,768
| +37% | +$91.9K | ﹤0.01% | 4192 |
|
|
2021
Q4 | $207K | Hold |
37,468
| – | – | ﹤0.01% | 4334 |
|
|
2021
Q3 | $343K | Hold |
37,468
| – | – | ﹤0.01% | 4126 |
|
|
2021
Q2 | $416K | Buy |
+37,468
| New | +$416K | ﹤0.01% | 3928 |
|
|
2018
Q1 | – | Sell |
-76
| Closed | -$30K | – | 3781 |
|
|
2017
Q4 | $30K | Hold |
76
| – | – | ﹤0.01% | 3667 |
|
|
2017
Q3 | $40K | Hold |
76
| – | – | ﹤0.01% | 3678 |
|
|
2017
Q2 | $66K | Sell |
76
-97
| -56% | -$84.2K | ﹤0.01% | 3573 |
|
|
2017
Q1 | $153K | Buy |
173
+78
| +82% | +$69K | ﹤0.01% | 3522 |
|
|
2016
Q4 | $274K | Buy |
+95
| New | +$274K | ﹤0.01% | 3465 |
|